<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CD8+ T-cells recognize antigenic <z:chebi fb="7" ids="16670">peptides</z:chebi> presented by major histocompatibility complex (MHC) class I molecules </plain></SENT>
<SENT sid="1" pm="."><plain>These <z:chebi fb="7" ids="16670">peptides</z:chebi> bind to MHC class I molecules in the endoplasmic reticulum (ER) lumen </plain></SENT>
<SENT sid="2" pm="."><plain>Antigenic <z:chebi fb="7" ids="16670">peptides</z:chebi> are translocated from the cytosol to the lumen of ER by transporter associated with antigen presentation (TAP) proteins </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, it is shown that TAP1 polymorphism influences the <z:chebi fb="7" ids="16670">peptide</z:chebi> substrate specificity in human B-lymphoblastoid and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell lines </plain></SENT>
<SENT sid="4" pm="."><plain>TAP1A and 1C alleles specifically enhance translocation of model <z:chebi fb="7" ids="16670">peptides</z:chebi> containing basic C-terminal amino acid residue </plain></SENT>
<SENT sid="5" pm="."><plain>However, TAP1B allele does not show specificity for the <z:chebi fb="7" ids="16670">peptide</z:chebi> C-terminus </plain></SENT>
<SENT sid="6" pm="."><plain>Human basophilic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (Ku812), and <z:hpo ids='HP_0001402'>hepatocellular carcinoma</z:hpo> (PLC/PRF/5) cells express TAP1 molecules and exhibit TAP-mediated allele-specific <z:chebi fb="7" ids="16670">peptide</z:chebi> uptake after gamma-interferon (gamma-IFN) treatment </plain></SENT>
<SENT sid="7" pm="."><plain>Ku812 cells express TAP1A and preferentially take up antigenic <z:chebi fb="7" ids="16670">peptides</z:chebi> with a basic C-terminus, however, PLC/PRF/5 cells with the TAP1B allele take up low but equivalent levels of <z:chebi fb="7" ids="16670">peptides</z:chebi> regardless of basic, acidic, or hydrophobic C-termini </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, TAP2 polymorphisms have no influence on the <z:chebi fb="7" ids="16670">peptide</z:chebi> translocation in <z:mpath ids='MPATH_458'>normal</z:mpath> or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell lines </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, Daudi, a beta2-microglobulin (beta2m) deficient human Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, cell line also showed TAP-dependent <z:chebi fb="7" ids="16670">peptide</z:chebi> uptake </plain></SENT>
<SENT sid="10" pm="."><plain>Taken together, these results suggest that human TAP1 but not TAP2 polymorphisms influence the antigenic <z:chebi fb="7" ids="16670">peptide</z:chebi> transport and that this transport is independent of beta2m in this system </plain></SENT>
</text></document>